KYINNO

KYinno is more than a CRO; we are the catalysts in the realm of preclinical cancer drug development. Our relentless pursuit of pioneering research, coupled with an innate ability to exceed client anticipations, fortifies our status as a dependable ally in the industry. Equipped with cutting-edge facilities and an innovation-centric team, we don't just contribute; we lead the charge in the advancements of preclinical research and drug discovery... Kyinno is a preclinical contract research organization (CRO) with decades of experience. We provide in vitro and in vivo pharmacology, cell line engineering, therapeutic target identification, and groundbreaking antibody discovery services.

Also known as: Kyinno Biotechnology, Kyinno Biotechnology Co., Ltd

Primary location: Waltham United States